Brazilian Clinical Research Institute
11
0
1
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 80/100
27.3%
3 terminated/withdrawn out of 11 trials
57.1%
-29.4% vs industry average
64%
7 trials in Phase 3/4
0%
0 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
Radical CystEctomy or RaDio-chEMotherapy as Preferred Treatment for invasivE blaDder Cancer
Role: lead
COACTION Trial - COmbination Androgen bloCkade in inTermediate to hIgh-risk prOstate caNcer
Role: lead
Anti-inflammatory and Anti-thrombotic Therapy With colcHicine and Low Dose Rivaroxaban for Major Adverse Cardiovascular Events Reduction in Ischemic Stroke
Role: lead
Cardiovascular Registry of Atrial Fibrillation
Role: lead
Fixed Combination of Dipirone and Codeine Compared to the Isolated Use of Dipyrone and Codeine in Controlling Pain After Pelvic-abdominal Surgery.
Role: lead
COVID-19 Antithrombotic Rivaroxaban Evaluation
Role: collaborator
Apixaban for PrOphyLaxis of thromboemboLic Outcomes in COVID-19
Role: lead
Quality of Life and Long-term Outcomes After Hospitalization for COVID-19
Role: collaborator
Full Anticoagulation Versus Prophylaxis in COVID-19: COALIZAO ACTION Trial
Role: lead
Safety and Efficacy of Tocilizumab in Moderate to Severe COVID-19 With Inflammatory Markers
Role: collaborator
Angiotensin Receptor Blockers and Angiotensin-converting Enzyme Inhibitors and Adverse Outcomes in Patients With COVID19
Role: collaborator
All 11 trials loaded